All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...

Dr. Mehmet Oz, the former surgeon and television host, was nominated to head the Centers for Medicare and Medicaid Services.

The selected drugs account for approximately $41 billion in total spending under Medicare Part D between November 2023 and October 2024, or about 14% of Medicare Part D's prescription drug costs, ...

The Trump administration signaled Medicare drug price negotiations under the Inflation Reduction Act (IRA) signed in 2022 by ...

In today's Pharmalittle roundup, we're reading about Medicare negotiations, U.K. drug rebates rising, and more.

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...

the authority to establish a program to negotiate Medicare drug prices with manufacturers. The goal is to make prescription drugs more affordable and accessible for patients, and to maintain the ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

Just before the inauguration, the outgoing Biden administration announced 15 new medications that'll be subject to government ...